Skip to main content
USPHU.S. Physical Therapy, Inc.Sell5.4·$99.55
SellModerate Confidence
Investment thesis

U.S. Physical Therapy offers 24% upside to analyst consensus targets and converts free cash flow at 124% of net income, but the company falls just below the $1 billion minimum market cap threshold for this investable universe, and a confirmed price downtrend combined with extremely elevated put-to-call options activity creates a difficult entry environment.

Thesis pillars

  • Analyst Target Upside→Stable
  • Free Cash Flow Conversion→Stable
  • Downtrend Below 200ma↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026· older than 90 days

Full reasoning →

Open full analysis

U.S. Physical Therapy, Inc. (USPH) Stock Analysis

SellModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $99.55 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (2.2% away).

U.S. Physical Therapy operates through two segments: physical therapy clinics providing orthopedic, sports-injury, and worker rehabilitation services, and an industrial injury prevention (IIP) segment contracting directly with employers, including Fortune 500 companies. The... Read more

$99.55-2.6% A.UpsideScore 5.4/10#22 of 35 Medical Care Facilities
QualityF-score6 / 9FCF yield3.14%
IncomeYield1.85%(5y avg 1.88%)Payout1011.11%at-risk
Stop $92.58Analyst target $97.00(reached)A.R:R -0.2:1
Analyst consensus$111.50+12.0%6 analysts with price targets
$99.55price
$111.50mean
$95
$122

Sell if holding. Analyst target reached at $99.55 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (2.2% away). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.4/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 99d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About U.S. Physical Therapy, Inc.

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy owned and/or managed 780 clinics across 44 states at December 31, 2025, generating $650.4 million in net patient revenue, up from $560.6 million in 2024. Managed care and commercial health insurance supplied 48.5% of net patient revenue and Medicare/Medicaid another 35.8%, with workers' compensation insurance contributing 10.2%. The company's highest clinic concentration is in Texas, Tennessee, Michigan, New York, and Virginia, among other states.

U.S. Physical Therapy earns physical therapy revenue on a per-procedure, outpatient basis, generally structured through Clinic Partnerships in which the company holds a 65% to 75% typical equity stake (ranging 30% to 99%) alongside physical therapist partners who retain minority interests, receive base salaries, and can earn bonuses tied to their clinic's profitability. Departing partners' interests are subject to put and call rights priced at a predetermined multiple of clinic earnings. The IIP segment operates on a different model, contracting directly with employers, including a number of Fortune 500 companies, for onsite injury prevention, performance optimization, and ergonomic assessment services rather than billing third-party payors. Growth comes largely through acquisitions: the company completed multi-clinic transactions at ownership stakes ranging from 40% to 80% during 2023-2025, plus 14, 8, and 9 tuck-in clinic acquisitions in 2025, 2024, and 2023, respectively.

Show full overview

U.S. Physical Therapy's revenue is directly exposed to the annual Medicare Physician Fee Schedule cycle: the 10-K discloses MPFS reimbursement cuts of 3.5%, 0.75%, 2.0%, 1.8%, and 1.5% for calendar years 2021 through 2025, respectively, before an expected 1.75% increase in 2026. With Medicare and Medicaid patients accounting for 35.8% of net patient revenue and 40.1% of visits in 2025, a return to the multi-year pattern of MPFS cuts — which regulators have imposed in four of the last five years — would pressure per-visit economics more than a single bad year of managed-care contract renegotiations.

See also: Healthcare · Medical Care Facilities

From U.S. Physical Therapy, Inc.'s most recent 10-K filing, extracted July 6, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

No fresh coverage since Oct 28, 2026

Recent Developments — U.S. Physical Therapy, Inc.

Latest item Oct 28, 2026 · Generated 2026-11-17T11:52:26Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Feb 24, 202799d to earnings· next earnings call

Thesis

Rewards
Positive momentum
Risks
Analyst target reached - limited upside remaining
Near 52-week high (2.2% away)
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)—
P/E (Fwd)29.6
Mkt Cap$1.5B
EV/EBITDA20.7
Profit Mgn3.6%
ROE6.3%
Rev Growth13.1%
Beta1.13
Dividend1.85%
Analysts with ratings13

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.19bullish
IV67%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMregulatoryMedicare/Medicaid36%
    10-K Item 1: 'approximately 40.1% of our visits and 35.8% of our net patient revenue was from patients with Medicare or Medicaid program coverage'
  • MEDIUMCustomercommercial health insurers, HMOs, PPOs, and workers' compensation insurers
    10-K Item 1: 'Our physical therapy business depends to a significant extent on our relationships with commercial health insurers, health maintenance organizations, preferred provider organizations and workers' compensation insurers.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
1.0
Earnings History
1.1
Dividend Safety
3.5
Erm
5.0
Earnings Timing
5.0
News Activity
6.0
Earnings concerns: 1B/2M
GatesA.R:R -0.2=NEGATIVEMomentum 7.5>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 99d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
76 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $79.39Resistance $101.33

Price Targets

A.Upside-2.6%
A.R:R-0.2:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeCautious

Risk Alerts

! Target reached (-2.6% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
M
M
M
1/4 beats
Next Earnings2027-02-24 (99d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is USPH stock a buy right now?

Sell if holding. Analyst target reached at $99.55 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (2.2% away). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $92.58. Score 5.4/10, moderate confidence.

What is the USPH stock price target?

Analyst target $97.00 reached (−2.6% from $99.55); no take-profit level is published. Prior stop was $92.58. Stop-loss: $92.58.

What are the risks of investing in USPH?

Analyst target reached - limited upside remaining; Near 52-week high (2.2% away); Consecutive earnings misses (2).

Is USPH overvalued or undervalued?

U.S. Physical Therapy, Inc. trades at a P/E of N/A (forward 29.6). TrendMatrix value score: 4.1/10. Verdict: Sell.

What do analysts say about USPH?

13 analysts rate USPH, with a consensus score of 4.2/5. 6 analysts publish price targets averaging $112.

What does U.S. Physical Therapy, Inc. do?U.S. Physical Therapy operates through two segments: physical therapy clinics providing orthopedic, sports-injury, and...

U.S. Physical Therapy operates through two segments: physical therapy clinics providing orthopedic, sports-injury, and worker rehabilitation services, and an industrial injury prevention (IIP) segment contracting directly with employers, including Fortune 500 companies. The company owned and/or managed 780 clinics across 44 states at year-end 2025, generating $650.4 million in net patient revenue primarily through majority-owned Clinic Partnerships with local physical therapists.

Related stocks: SRTA (Strata Critical Medical, Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · DVA (DaVita Inc.) · GMRS (GMR Solutions Inc.)
Home › Stocks › USPH

Latest news

Latest News

MarketBeat202d agoEarnings
TradingView20d agoEarnings
Yahoo Finance195d agoEarnings
StockStory195d agoEarnings
Marketscreener.com195d agoEarnings
Yahoo Finance195d agoEarnings
Marketscreener.com104d agoEarnings
StockStory196d agoEarnings
FinancialContent196d agoEarnings
DirectorsTalk Interviews105d ago
StockStory105d agoEarnings
Dars.gov.et110d ago
TradingKey110d ago
TradingKey110d ago
Tradingkey.com110d ago
Tradingkey.com110d ago
TradingKey110d ago
Insider Monkey201d ago
Yahoo Finance194d agoEarnings
Yahoo Finance103d ago
Loading more...